For AI assistants & researchers — machine-readable summary of this page
What this page is: Delvantic's full research page for Cognizant Technology Solutions Corporation (CTSH) — AI-driven forensic equity research: mechanical valuation models (DCF, EPV, anchored-PE, scenario) plus three independent AI lenses (Quality / Value / Sentiment). Everything below is rendered server-side; you are not missing content that requires JavaScript. All scores are predictions and research opinions, not financial advice.
Our current read (analysis of 2026-08-23): Designation Watch · Gem Score +33 (−100…+100 Quality+Value blend) · Quality 32 · Value 33 · Sentiment -36 (timing only, not weighted) · Composite fair value $69.93 vs $57.27 at analysis
Page map (sections in order; each card carries a stable
reference-name attribute you can cite):
profile-header/price-overview— company profile, live quote, market capextended-analysis— the core: three AI lens reads with findings, scores, and the analyst memofuture-predictions— our forward price-band predictionsmarket-narrative/ai-findings/gpt-critique— narrative context, cross-model findings, and an adversarial critique of our own analysis (near the end of the document)- Members-only sections (render as login gates for anonymous readers):
price-history,income-trend,key-metrics,financials(statement tables),insider-trading. The analysis above is public; the raw data tables require a free account.
More for machine readers: site briefing at
/llms.txt ·
any ticker resolves at delvantic.com/stock/TICKER ·
raw inputs are public-company filings and market data (via licensed data feeds);
every model, score, lens read, and prediction on this page is Delvantic's own analysis.
Cognizant Technology Solutions Corporation
CTSH NASDAQCognizant Technology Solutions Corporation is a global professional services and technology company headquartered in Teaneck, New Jersey, founded in 1994. The company focuses on helping enterprises modernize their technology stacks, become data-enabled, and apply artificial intelligence to improve decision-making and operations. Cognizant provides consulting, systems integration, application development and maintenance, cloud migration, digital engineering, and business process services to clients across industries such as financial services, healthcare, life sciences, manufacturing, retail, and communications. It plays a significant role in large-scale digital transformation programs, including modernizing legacy systems, implementing cloud and SaaS platforms, and optimizing processes through automation and analytics. By combining domain expertise with technology capabilities, Cognizant serves as a strategic partner to corporations and institutions seeking to enhance efficiency, improve customer experience, and manage complex IT and operational environments in an increasingly digital and AI-driven market.
Price Overview
Price History (1 Year)
Revenue & Net Income Trend
| Period | Revenue | Net Income | Net Margin | YoY/QoQ |
|---|
Key Metrics
EPS (Diluted): 4.56
Total Equity: $15.02B
Shares: 489,000,000
Total Debt: $576.00M
Cash: $1.90B
EBITDA: $3.94B
Total Debt: $576.00M
Cash: $1.90B
Revenue: $21.11B
Revenue: $21.11B
Revenue: $21.11B
Total Equity: $15.02B
Tax Rate: 36.2%
Equity: $15.02B
Total Debt: $576.00M
Cash: $1.90B
Current Liabilities: $3.66B
Long-Term Debt: $543.00M
Total Debt: $576.00M
Total Equity: $15.02B
Shares: 489,000,000
Shares: 489,000,000
CapEx: -$288.00M
Shares: 489,000,000
Stock Price: $55.39
Net Income: $2.23B
Industry Benchmarks
Income Statement (Annual)
Last updated: Aug 3, 2026 1:08pm (20d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $18.5B | $19.4B | $19.4B | $19.7B | $21.1B |
| Cost of Revenue | $11.6B | $12.4B | $12.7B | $13.0B | $14.0B |
| Gross Profit | $6.9B | $7.0B | $6.7B | $6.8B | $7.1B |
| Operating Expenses | $4.1B | $4.0B | $4.0B | $3.9B | $3.7B |
| Operating Income | $2.8B | $3.0B | $2.7B | $2.9B | $3.4B |
| Net Income | $2.1B | $2.3B | $2.1B | $2.2B | $2.2B |
| EBITDA | $3.4B | $3.5B | $3.2B | $3.4B | $3.9B |
| EPS | $4.06 | $4.42 | $4.21 | $4.52 | $4.57 |
| EPS (Diluted) | $4.05 | $4.41 | $4.21 | $4.51 | $4.56 |
Balance Sheet (Annual)
Last updated: Aug 3, 2026 12:43pm (20d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | $1.8B | $2.2B | $2.6B | $2.2B | $1.9B |
| Total Current Assets | $7.3B | $7.3B | $7.5B | $7.5B | $7.8B |
| Total Assets | $17.9B | $17.9B | $18.5B | $20.0B | $20.7B |
| Current Liabilities | $3.5B | $3.3B | $3.3B | $3.6B | $3.7B |
| Long-Term Debt | $626.0M | $638.0M | $606.0M | $875.0M | $543.0M |
| Total Liabilities | $5.9B | $5.5B | $5.3B | $5.6B | $5.7B |
| Total Equity | $12.0B | $12.3B | $13.2B | $14.4B | $15.0B |
| Retained Earnings | $11.9B | $12.6B | $13.3B | $14.7B | $15.2B |
Cash Flow (Annual)
Last updated: Aug 3, 2026 1:08pm (20d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | $2.5B | $2.6B | $2.3B | $2.1B | $2.9B |
| Capital Expenditure | -$279.0M | -$332.0M | -$317.0M | -$297.0M | -$288.0M |
| Free Cash Flow | $2.2B | $2.2B | $2.0B | $1.8B | $2.6B |
| Acquisitions (net) | -$970.0M | -$367.0M | -$409.0M | -$1.6B | $0 |
| Net Debt Issued / (Repaid) | $0 | $650.0M | $0 | $0 | — |
| Dividends Paid | -$509.0M | -$564.0M | -$591.0M | -$600.0M | -$610.0M |
| Stock Buybacks | -$771.0M | -$1.4B | -$1.1B | -$605.0M | -$1.4B |
| Net Change in Cash | -$888.0M | $502.0M | $423.0M | -$486.0M | $403.0M |
Growth Trends (YoY %)
Last updated: Aug 3, 2026 1:08pm (20d ago)| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue Growth | +5.0% | -0.4% | +2.0% | +7.0% |
| Gross Profit Growth | +1.1% | -4.2% | +1.3% | +5.0% |
| Operating Income Growth | +5.0% | -9.4% | +7.5% | +17.2% |
| Net Income Growth | +7.2% | -7.2% | +5.4% | -0.4% |
| EBITDA Growth | +4.0% | -8.3% | +5.9% | +14.7% |
Dividend History (Last 20)
Last updated: Aug 3, 2026 12:43pm (20d ago)| Date | Dividend | Declaration | Record | Payment |
|---|---|---|---|---|
| 2026-08-18 | $0.33 | — | — | — |
| 2026-05-18 | $0.33 | — | — | — |
| 2026-02-18 | $0.33 | — | — | — |
| 2025-11-18 | $0.31 | — | — | — |
| 2025-08-18 | $0.31 | — | — | — |
| 2025-05-19 | $0.31 | — | — | — |
| 2025-02-18 | $0.31 | — | — | — |
| 2024-11-19 | $0.30 | — | — | — |
| 2024-08-20 | $0.30 | — | — | — |
| 2024-05-17 | $0.30 | — | — | — |
| 2024-02-16 | $0.30 | — | — | — |
| 2023-11-20 | $0.29 | — | — | — |
| 2023-08-18 | $0.29 | — | — | — |
| 2023-05-18 | $0.29 | — | — | — |
| 2023-02-16 | $0.29 | — | — | — |
| 2022-11-17 | $0.27 | — | — | — |
| 2022-08-18 | $0.27 | — | — | — |
| 2022-05-19 | $0.27 | — | — | — |
| 2022-02-17 | $0.27 | — | — | — |
| 2021-11-18 | $0.24 | — | — | — |
Deep Analysis
Narrative Economics
market-narrative step).
AI Lens 4th lens · how AI reaches this business · 5-yr
2026-08-17Enterprise AI adoption creates a genuine multi-year wave of paid work — legacy data plumbing, application modernization, agent integration, governance and change management — that clients cannot staff internally, and Cognizant is currently winning share (+3.1% vs industry) inside a flat 4.2% CAGR market.
The core scarce asset is a trained, low-cost offshore labor pyramid, and the same capability that makes AI useful to clients makes that pyramid abundant; as multi-year contracts come up for rebid, procurement will demand the productivity gain back, compressing the effort-based revenue unit faster than headcount can be repriced.
Whether AI productivity lands as margin or as price concession. It shows up in revenue per employee rising alongside stable-or-better gross margin — GM% has fallen five straight years from 37.3% to 33.7%, so a break in that slide is the single cleanest signal.
Deeply embedded run-the-business contracts in regulated verticals (healthcare payers, BFSI), the TriZetto healthcare platform IP and its claims-workflow position, plus enterprise procurement standing and global delivery scale that AI-native services boutiques cannot bid against on large programs.
AI Lens thesis
The customer need — build, integrate and operate enterprise technology — persists and arguably intensifies, but Cognizant's solution to that need is arbitraged labor, and its price is a function of bodies and hours. Cheap intelligence therefore hits the revenue line and the asset base simultaneously: it shrinks the number of billable people required per unit of client outcome, and it erodes the scarcity of the offshore engineering pool that justified the arbitrage. Offsetting this, delivery cost falls too, and clients are unwilling to own the messiness of legacy modernization, so the demand pipeline swells first. The five-year question is sequencing and value capture: the demand bulge arrives before the repricing, and in a fragmented bid market with TCS, Infosys, Accenture and AI-native challengers all holding the same tools, the base case is that most of the productivity is competed away into price rather than retained. Operating margin recovering to 16.1% and FCF jumping to $2.60B show the company is currently on the favorable side of that sequence.
What the market may be underestimating
Upside If AI genuinely collapses delivery headcount, Cognizant becomes a far less capital- and people-intensive cash machine; sustained buybacks (528M→489M shares) against $2.6B FCF on a structurally lighter cost base is a quietly powerful arithmetic that the 'commoditized services' framing ignores.
Downside AI eats the bottom of the pyramid first, and the junior-heavy leverage is precisely where utilization margin is manufactured; a flatter pyramid can raise revenue per head while lowering gross margin. Multi-year contract structures also delay visible compression until rebid, so reported numbers can look fine right up to a step-down.
Outcome range spread 44
Growth Outlook
Analyzed 2026-08-17 16:28The question every valuation on this page silently assumes: is this company likely to grow? Judged forward — the business, its category, the world — against what's already printed.
Claude Reading
The raw quarterly tape is more interesting than the "mature IT services" caricature suggests. Revenue went $4.85B → $5.04 → $5.08 → $5.12 → $5.25 → $5.42 → $5.33 → $5.41B over eight quarters — that's ~11.5% cumulative, or roughly 7% YoY on the most recent print, which is not a company in structural decline. Net income is lumpier ($274M in Q3 2025 is a clear outlier — likely restructuring or a legal charge worth diligencing before trusting the "12.2% steady-state margin" read), but four of the last five quarters cluster at 12-13% net margin, meaningfully above the 10.6% TTM figure the canonical metrics table shows. Operating margin expanded from 14.6% in FY23 to 16.1% in FY25 on 9% cumulative revenue growth — that is operating leverage, not commoditization. FCF of $2.60B on a $26.5B market cap is a 9.8% FCF yield, and net debt is essentially zero ($576M debt vs $1.90B cash).
Where I push back on the synthesis: the $70-76 fair-value composite feels directionally right but the "undervalued +31%" framing overreaches given what's actually knowable. The reverse-DCF implying -3.2% FCF contraction is a fair characterization of the setup, but flip it — the market has been telling this story about CTSH for five years and the company has still compounded FCF at 13.5%. That's the tell. The bear case (GenAI disintermediates services) is the same bear case that's been priced in since 2019 when CTSH traded at 15x; the multiple has actually compressed while FCF grew. Either the bears are finally right and the reckoning is imminent, or the market is anchored to a narrative that fundamentals keep quietly refuting. I lean toward the latter but with less conviction than the synthesis's +31% number implies.
The contrarian counter is real and I'll voice it: revenue growth is 4.4% CAGR over five years, earnings CAGR is 2.4%, and the "acceleration" to 7% YoY could be Belcan acquisition contribution rather than organic — the file doesn't disaggregate. If organic is still 3-4%, this is a 12.7x P/E for a company barely outpacing inflation, and re-rating requires either sustained 6%+ organic growth or a GenAI-services narrative shift that management has not yet demonstrated. ACN at ~22x isn't the right comp if CTSH's organic growth is half of ACN's. The insider activity is also not "net buying" in any meaningful sense — these are option exercises with sales to cover taxes, which is neutral-to-slightly-negative housekeeping, not conviction. The secondary signal calling this "Net Insider Buying" is misreading Form 4 mechanics. Also flag: the Q1 2026 print dated 2026-03-31 with insider activity dated July 2026 means this dataset is forward of today's calendar or the dates are mislabeled — worth verifying before sizing anything.
Net: I partially agree with the undervalued call but at a lower magnitude. Fair value is more like $65-70 than $76, which still implies 12-20% upside plus a 2.25% dividend — a respectable but not table-pounding setup. The bull case doesn't need GenAI heroics; it just needs organic growth to stay at 4-5% while margins hold at 16%, and the multiple to drift from 12.7x to 14-15x as the "structural decline" narrative gets falsified quarter by quarter. The bear case needs a specific catalyst (client budget cut, big deal loss, Belcan integration miss) that isn't in the data. On risk-adjusted basis, this is a reasonable long for a value/income sleeve, not a high-conviction mispricing. I'd want to see the Q3 2025 net income anomaly explained and organic vs. inorganic growth disaggregated before pressing size.
GPT Reading
What stands out to me is that Cognizant is being valued like a melting-ice-cube outsourcer when the actual numbers show a business that is at least stable and lately reaccelerating. Revenue went from $19.35B in 2023 to $19.74B in 2024 and then to $21.11B in 2025, a 6.9% increase last year, and the quarterly run-rate has stepped up from $4.85B in June 2024 to $5.41B in March 2026. On the balance sheet, this is not a stressed story: $1.90B of cash against just $576M of debt leaves net cash of roughly $1.3B. Cash generation is also real. 2025 operating cash flow was $2.88B and free cash flow was $2.60B, which against a $26.5B market cap is about a 9.8% FCF yield. For a capital-light services company with mid-teens ROIC of 15.8% and ROE of 14.9%, that is plainly cheap unless earnings are about to roll over.
The margin picture is better than the bear case implies, though not immaculate. Annual operating income rose from $2.89B in 2024 to $3.39B in 2025, lifting operating margin from 14.6% to 16.1% on the back of stronger revenue and cost discipline. Gross margin in 2025 was 33.7%, not spectacular but consistent with a healthy services model. Net income for 2025 was $2.23B, basically flat with 2024’s $2.24B only because one quarter in late 2025 cratered to a 5.1% net margin on $5.42B of revenue. That quarter is the obvious blemish, but it also looks isolated: the surrounding quarters were all around 12%-13% net margin, including $663M on $5.12B in March 2025, $645M on $5.25B in June 2025, $648M on $5.33B in December 2025, and $662M on $5.41B in March 2026. If the normalized earnings power is roughly $2.5B to $2.6B annualized from those cleaner quarters, then the headline 12.7x P/E is arguably overstating the true multiple; on normalized earnings, the stock is closer to 10x-11x for a business that is still growing.
That is why I do not buy the more cautious model outputs leaning toward “mature earner, maybe neutral.” Mature, yes; ex-growth, no. The recent quarterly revenue growth is not explosive, but it is broad enough to matter: March 2026 revenue of $5.41B versus $5.12B a year earlier is up about 5.7%, and December 2025 at $5.33B versus $5.08B a year earlier is up 4.9%. The market cap is only 1.34x sales and EV/revenue 1.28x for a company producing double-digit net margins, low leverage, and a dividend yield of 2.25% with a modest 27% payout ratio. You do not need an AI miracle for this to work. You only need Cognizant to keep doing roughly what it is doing: low-single-digit to mid-single-digit growth, hold operating margin around 15%-16%, and convert earnings into cash. On those terms, $57-58 looks discounted; a fairer range is in the high $60s to low $70s.
The best case against this view is that 2025’s revenue improvement may have come late in the cycle and could reverse if enterprise tech spending softens, while AI compresses labor-based services pricing faster than Cognizant can move up the value chain. The ugly September 2025 quarter matters because it may not be a one-off; it may be an early warning that project mix, pricing, or restructuring costs are becoming more volatile. Also, annual net income did not grow from 2024 to 2025 despite the $1.37B increase in revenue, which is a legitimate challenge to any “turnaround” narrative. If a business adds nearly 7% revenue and cannot translate that into net income growth, maybe the structural margin ceiling is lower than the current operating margin suggests. And while 12.7x earnings looks cheap against higher-multiple peers, some of that discount is deserved because Cognizant has posted only a 4.4% revenue CAGR and 2.4% earnings CAGR over the period shown—hardly evidence of a premium operator.
What would change my mind is straightforward. If the next few quarters slip back below $5.2B of revenue or net margin stays closer to 10%-11% instead of returning to the 12%+ pattern, then the “normalized earnings” case is wrong and the low multiple is deserved. Likewise, if annual free cash flow falls meaningfully below $2.3B without a clear reinvestment payoff, the 10% FCF yield is an illusion rather than value. On the other hand, if Cognizant can sustain quarterly revenue above $5.3B and keep quarterly net income around $630M-$670M, the stock should not sit at 12x earnings with net cash and solid capital returns. That combination would support a rerating toward at least $68 and plausibly $72.
Grok Reading
The numbers describe a capital-light cash compounder the market has abandoned. Cognizant put up $21.11B in 2025 revenue, up roughly 7% from $19.74B, with free cash flow of $2.60B on only $288M of capex and a net-cash balance sheet ($1.90B cash against $576M debt). Trailing net income of $2.23B is essentially flat versus the prior four years, yet operating cash conversion is excellent and the trailing FCF yield at $57.75 is nearly 10%. Multiples—12.7× earnings, 6.8× EV/EBITDA, 1.34× sales—embed a reverse-DCF assumption of multi-year free-cash-flow contraction. That is the core dislocation: recent quarterly revenue run-rate has stepped up to the mid-$5.3–5.4B range (from low-$5B a year earlier), operating margins have re-expanded to 16%, and net margins outside one anomalous quarter sit at 12%+. The business is not dying; it is being priced as if it is.
The single ugly print—September 2025 net income of only $274M and a 5.1% margin—stands out against an otherwise steady 10.7–13% band and is almost certainly a discrete charge rather than structural collapse, because the two subsequent quarters snapped straight back to $648M and $662M. ROIC of 15.8% and ROE of 14.9% on a fortress balance sheet (debt-to-equity 0.04, current ratio 2.1) leave ample room to keep returning capital via the 2.25% dividend and buybacks. At these multiples the stock does not need a growth renaissance; it merely needs to avoid the permanent decline the market has already discounted. A re-rating toward even a mid-teens earnings multiple, still well below premium IT-services peers, would push the shares into the low-to-mid $70s—the same neighborhood the composite models flag.
The strongest counter-case is straightforward and not trivial. IT services remain a labor-arbitrage business facing genuine disintermediation risk from generative AI tools that let clients do more with fewer billable hours; the same automation that can expand Cognizant’s own delivery margins can shrink the addressable pool of traditional application-maintenance and integration work. Revenue CAGR over five years is only 4.4% and earnings CAGR 2.4%; the recent 7% top-line pop could easily prove cyclical rather than structural. Wage inflation in India continues to compress the cost advantage that underpins the entire offshore model, and the competitive set (Accenture, TCS, Infosys, and increasingly the hyperscalers themselves) is intensifying. The September 2025 earnings air-pocket, even if one-time, is a reminder that large charges can appear when utilization or large-deal timing slips. Insider activity is mostly option exercise and related sales, not conviction buying, so there is no insider vote of confidence to lean on. A smart bear simply says the 12.7× multiple is cheap for a reason and that the reverse-DCF’s implied contraction is the base case, not the bear case.
I would flip if two consecutive quarters show organic revenue growth re-accelerating through 8–9% with GenAI-related bookings explicitly quantified and expanding, or conversely if revenue growth falls back below 3% while operating margin compresses below 14% on a clean basis. Until then the asymmetry favors the long side at $58.
Big-3 Panel — where each AI stands
Advanced Analysis Forensic deep-dive · separate lenses
Cognizant is a classic mature earner: revenue crept from $18.5B (2021) to $21.1B (2025), a roughly 3.3% CAGR, while net income has been essentially flat around $2.1-2.3B for five years. FCF of $2.60B in 2025 is the strongest print in the window and comfortably exceeds net income (OCF/NI 1.13x, accruals -1.5% of assets), and mechanical earnings-quality checks are clean (Beneish -2.52, Altman Z 5.63). Balance sheet carries $1.91B liquid cash and $1.34B net cash, so the business is fully self-funding. Capital returns are disciplined: diluted share count fell from 528M to 489M (-1.9% CAGR), SBC is a modest 0.9% of revenue, and buybacks run 5x SBC, so per-share value is genuinely being concentrated rather than leaked. Operating margin recovered to 16.1% in 2025 after dipping to 13.9% in 2023, a real positive. The soft spot is gross margin, which has ground down every single year from 37.3% to 33.7% - a 360bp erosion suggesting pricing pressure, wage inflation, or unfavorable mix in a competitive IT-services market where offshore peers (Infosys, TCS, Accenture) crowd the same buyers. Insider tape is essentially non-directional: option exercises and tax withholdings dominate, the flagged 'net buying' is a trivial $210K vs $12K sold - not a real signal either way.
Verify before trusting this (6)
- Segment/geography detail on where the 360bp gross margin erosion originated - wage inflation, pricing, or mix
- Customer concentration disclosure in the 10-K (top 5/10 clients as % of revenue) given services industry norms
- Bookings/backlog trend and TCV of new deals to confirm the 2025 revenue reacceleration is durable
- Details of the Belcan and other recent acquisitions - purchase price, goodwill, and organic vs inorganic contribution to 2025 growth
- Attrition rates and headcount trends - key leading indicator for IT services quality
- Any exposure/strategy disclosure on GenAI cannibalization of application maintenance revenue
The e2e composite fair value of $70.01 and signal-adjusted $75.99 imply roughly 22-33% upside from the $57.27 price. The three methods cluster reasonably: DCF at $76.44, anchored P/E at $74.13, and an EPV floor at $53.03. That EPV floor is the key sanity check - it sits about 7% below today's price, meaning the market is paying only a modest premium to no-growth earnings power, which is a defensible starting point for a business the quality lens calls Solid with clean books and disciplined buybacks. Earnings quality is High, so no haircut is warranted; the deserved value stands as calculated. What is priced in at $57 is essentially stagnation - flat net income, continued gross margin bleed, and mediocre FCF conversion. What is NOT priced in is any credit for the 2025 op margin and FCF uptick sticking, or for capital returns compounding book value per share as the count shrinks. The gap is real but not extreme: this is a mature IT services name, not a special situation. A ~20-25% discount to deserved value on a Solid-quality compounder is the textbook 'modestly cheap' zone - worth owning, not worth backing up the truck.
Verify before trusting this (4)
- Whether the 2025 op margin and FCF improvement continues into next print or reverses
- Bookings and deal-pipeline commentary for signs of AI-driven pricing compression
- Management's forward capital return pace - buyback tempo vs share count
- Any guidance revision on organic revenue growth that would reset the DCF trajectory
The macro tape is modestly risk-on (VIX 14.3, S&P near highs) which is a small tailwind for equities broadly, but CTSH's 0.81 beta and defensive-ish IT services profile mean it captures little of that upside beat. There is no active narrative pulling this name higher: the archetype is 'steady compounder' with minimal intensity and low cult coefficient, so the stock lacks the story-driven bid that is inflating other tech cohorts in this environment. Meanwhile the market's dominant AI narrative is a two-edged sword that on balance leans against IT services incumbents - the fear is that agentic AI compresses billable-hours revenue, and today's MarketsandMarkets agentic AI headline reinforces exactly that framing even as CTSH tries to position itself on the winning side via the Benchling/Kyowa Kirin partnership. Analyst tone is neither bullish nor capitulating; the tape is just quietly ignoring the name. Net pressure is close to neutral, tilting a hair negative because the sector narrative is unfriendly and there is no offsetting catalyst or story momentum to reprice it.
Verify before trusting this (4)
- Whether peer IT services (INFY, WIT, ACN) start to break the AI-disruption narrative via reaccelerating bookings
- Any shift in sell-side tone or target revisions - currently quiet, but a downgrade cluster would tip sentiment negative fast
- Frequency and scale of CTSH's own AI-partnership headlines - needs to become a drumbeat, not one-offs, to build a counter-narrative
- A rotation from mega-cap AI winners into 'AI enablers/beneficiaries' laggards, which could pull CTSH along
The customer need — build, integrate and operate enterprise technology — persists and arguably intensifies, but Cognizant's solution to that need is arbitraged labor, and its price is a function of bodies and hours. Cheap intelligence therefore hits the revenue line and the asset base simultaneously: it shrinks the number of billable people required per unit of client outcome, and it erodes the scarcity of the offshore engineering pool that justified the arbitrage. Offsetting this, delivery cost falls too, and clients are unwilling to own the messiness of legacy modernization, so the demand pipeline swells first. The five-year question is sequencing and value capture: the demand bulge arrives before the repricing, and in a fragmented bid market with TCS, Infosys, Accenture and AI-native challengers all holding the same tools, the base case is that most of the productivity is competed away into price rather than retained. Operating margin recovering to 16.1% and FCF jumping to $2.60B show the company is currently on the favorable side of that sequence.
Verify before trusting this (8)
- ADM revenue trend
- Testing and support line disclosure
- Per-seat automation claims by rivals
- Share of fixed-fee/outcome contracts
- Disclosed pricing model shift
- Revenue per employee vs headcount
- Headcount vs revenue divergence
- Managed services vs project mix
IT services is mid-cycle-mature: enterprise budgets are flat-to-down in real terms under 4.6% long rates and macro headwinds, but spend is consolidating onto fewer large vendors, which is why a mature 4% industry can still hand a scaled incumbent 6-7% growth. The genuine world change is AI's effect on the billing unit: services revenue historically scaled with people, and any real productivity gain arrives at the client first as a price cut and only later as new AI-build revenue. That makes the near-term revenue line safer than it looks and the 2-3 year earnings line riskier than the revenue line suggests. CTSH's answer — scale, sticky multi-year run contracts, vertical depth in healthcare/BPS and engineering — buys time and share but does not yet demonstrate a repriced, higher-value unit of work.
When we made this prediction on Aug 18, 2026, CTSH was $56.61. We expect it to be $63.80 by Feb 2027, and we consider it great value under $52.00. This is an early model (v0.6.0) — the direction is more reliable than the exact price. Made Aug 18, 2026.
Blue is our prediction, starting the day we made it. Grey is a slower route to the same place — the same destination, taking longer. Black is the actual price, so you can see how we are doing.